Infobird Co., Ltd. (IFBD) is a Beijing-based provider of AI-powered customer-engagement software delivered mainly through a SaaS model, along with CRM, business-process outsourcing, and AI sales-force tools. With roughly 48 employees and a market capitalization near $7–8 million, it is a micro-cap with essentially no credible sell-side price-target coverage. I checked this using Tickeron’s AI Screener to confirm the lack of active analyst estimates.
Because no usable analyst price targets exist, $2.18 was derived as a fallback objective rather than a consensus. It corresponds to the stock's 52-week high of $2.175, a publicly visible technical milestone. This is not an analyst price target and should not be read as one. For context, the only recent rating is a Sell from Weiss Ratings, which carries no published target, while a Maxim Group Buy rating with a target of roughly $8–12 dates to 2021 — before the company's subsequent reverse stock splits (1-for-8 in March 2024 and 1-for-5 in May 2026) — and is therefore not comparable. Simply Wall St lists a discounted-cash-flow "fair value" near $30, but that is a model estimate, not a published analyst target.
The latest verified close for IFBD is about $1.03. Reaching $2.18 would require upside of roughly 112%, a very large move by any standard. The 52-week range spans $0.66 to $2.175, so the objective is a level the stock has already traded at within the past year — but reclaiming it would require a sustained re-rating from current levels.
The company reported revenue of roughly $8.7 million for fiscal 2025 against substantial net losses, and trailing-twelve-month EPS is deeply negative. With an Altman Z-Score near -13 and repeated reliance on reverse splits to maintain Nasdaq's minimum-bid requirement, the path toward $2.18 would hinge less on fundamentals and more on speculative repositioning, news-driven momentum, or a credible turnaround in revenue and profitability.
Any move toward $2.18 would most likely require a combination of factors. A meaningful return to revenue growth and a narrowing of net losses could improve the micro-cap's valuation appeal. As an AI-themed software name, IFBD could also benefit from broader investor enthusiasm for artificial-intelligence and SaaS equities. The stock's very small float of roughly 8.2 million shares means that even modest buying interest can produce outsized percentage moves — the recent 37% single-session jump illustrates that volatility can work in either direction.
The obstacles are significant. The company is unprofitable, with trailing net losses far exceeding annual revenue. It has registered an F-3 shelf allowing offerings of up to $300 million in securities, and independent trackers flag high dilution risk — shareholders were diluted by roughly 47% over two years. Repeated reverse stock splits have already compressed the share count, and DilutionWatch estimates a meaningful probability of another reverse split as the stock sits near the $1 Nasdaq minimum-bid threshold. An Altman Z-Score near -13 signals elevated financial-distress risk, and the absence of buy-rated sell-side coverage leaves few institutional catalysts.
The most durable technical reference points are the 52-week low near $0.66 and the 52-week high near $2.175. The $1.00 level is a psychological threshold and, more importantly, the Nasdaq minimum-bid benchmark the company must hold to avoid delisting-related pressure. The $2.18 objective sits just above the prior peak, meaning the stock would first need to break back through its recent range and sustain momentum well above $1.00 before a run at the high becomes plausible.
Because $2.18 is a technical milestone rather than an analyst target, there is no attached research horizon. Investors should monitor quarterly and annual filings for revenue trajectory and net-loss progress, any new share offerings or dilution under the $300 million shelf, reverse-split or Nasdaq compliance announcements, and changes to the single Sell rating currently outstanding. Broader AI-sector sentiment and any shift in institutional positioning in this lightly covered name also matter.
The $2.18 objective for Infobird (IFBD) is a technical milestone — the 52-week high — not an analyst consensus, and reaching it would require a very large move of roughly 112% from the latest close near $1.03. The theoretical supports are the small float and potential AI-sector sentiment, while the practical obstacles — persistent losses, dilution risk, reverse-split history, and Nasdaq compliance pressure — are substantial. There is no credible analyst coverage to anchor the stock forecast, so investors should treat any price objective here with caution and watch fundamentals, capital-raising activity, and compliance developments closely before drawing conclusions.
In my own workflow I frequently review Tickeron’s AI Daily Buy/Sell Signals when following thinly covered names like this one. The tool applies AI to scan thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on technical and market-condition shifts. It serves as a useful overlay for monitoring momentum in volatile micro-caps without replacing independent analysis.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The RSI Indicator for IFBD moved into overbought territory on November 02, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
The 10-day moving average for IFBD crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IFBD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
IFBD broke above its upper Bollinger Band on November 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for IFBD entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 65 of 70 cases where IFBD's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on IFBD as a result. In 83 of 105 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.
The Moving Average Convergence Divergence (MACD) for IFBD just turned positive on November 02, 2026. Looking at past instances where IFBD's MACD turned positive, the stock continued to rise in 42 of 49 cases over the following month. The odds of a continued upward trend are 86%.
IFBD moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +18.72% 3-day Advance, the price is estimated to grow further. Considering data from situations where IFBD advanced for three days, in 163 of 204 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
The Tickeron PE Growth Rating for this company is 34 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 40 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.215) is normal, around the industry mean (-1.884). P/E Ratio (-0.000) is within average values for comparable stocks, (15.540). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.824). Dividend Yield (0.000) settles around the average of (0.072) among similar stocks. P/S Ratio (0.911) is also within normal values, averaging (70.854).
The Tickeron Price Growth Rating for this company is 80 (best 1 - 100 worst), indicating slightly worse than average price growth. IFBD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IFBD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry PackagedSoftware